Loading…

Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension

The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and experimental hypertension (1993) 2011-08, Vol.33 (5), p.309-315
Main Authors: Sakima, Atsushi, Ohshiro, Katsuhiko, Nakada, Seigo, Yamazato, Masanobu, Kohagura, Kentaro, Nakamoto, Minori, Tana, Takeshi, Ohya, Yusuke
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13
cites cdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13
container_end_page 315
container_issue 5
container_start_page 309
container_title Clinical and experimental hypertension (1993)
container_volume 33
creator Sakima, Atsushi
Ohshiro, Katsuhiko
Nakada, Seigo
Yamazato, Masanobu
Kohagura, Kentaro
Nakamoto, Minori
Tana, Takeshi
Ohya, Yusuke
description The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.
doi_str_mv 10.3109/10641963.2010.549260
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3109_10641963_2010_549260</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>879480710</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</originalsourceid><addsrcrecordid>eNp9kcFu1DAURSMEoqXwBwh5xyrFdmIn2YDagdKRikC0sLWc-Lnj4tjBdtROv4WPxdO0SGy6suV37r3Wu0XxmuDDiuDuHcG8Jh2vDinOT6zuKMdPin3CKCs5xvxpvmek3DF7xYsYrzAmNWft82KPEl53jLb7xZ_za5OGjXGX6GIDQU5bpIMf0U8ZjOwtlB99BPRltslMFtA3Yy1KHp2YG1DL7DxrM3c3WfmxN04m411EXqMjd2l8AheNQ-s1-g4DTMkHdGz98AtCRNKpnGvkrVEQkc6j0-0E4U7i3cvimZY2wqv786D4cfLpYnVann39vF4dnZVD3Vap5JLwSktSt03TdLWiWDOqKNVYDSBZxTuOOe81rWTf4rpRnAOHppKKMa6AVAfF28V3Cv73DDGJ0cQBrJUO_BxFm11b3BCcyXohh-BjDKDFFMwow1YQLHa1iIdaxK4WsdSSZW_uA-Z-BPVP9NBDBj4sgHF5CaO89sEqkeTW-qCDdIOJO_tHI97_57ABadNmkAHElZ-Dy_t7_I9_AeeXsVE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>879480710</pqid></control><display><type>article</type><title>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Sakima, Atsushi ; Ohshiro, Katsuhiko ; Nakada, Seigo ; Yamazato, Masanobu ; Kohagura, Kentaro ; Nakamoto, Minori ; Tana, Takeshi ; Ohya, Yusuke</creator><creatorcontrib>Sakima, Atsushi ; Ohshiro, Katsuhiko ; Nakada, Seigo ; Yamazato, Masanobu ; Kohagura, Kentaro ; Nakamoto, Minori ; Tana, Takeshi ; Ohya, Yusuke</creatorcontrib><description>The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.</description><identifier>ISSN: 1064-1963</identifier><identifier>EISSN: 1525-6006</identifier><identifier>DOI: 10.3109/10641963.2010.549260</identifier><identifier>PMID: 21649528</identifier><language>eng</language><publisher>England: Informa Healthcare</publisher><subject>adherence ; Aged ; Angiotensin II Type 1 Receptor Blockers - administration &amp; dosage ; Antihypertensive Agents - administration &amp; dosage ; Blood Pressure - drug effects ; combination therapy ; Drug Combinations ; Female ; Humans ; hydrochlorothiazide ; Hydrochlorothiazide - administration &amp; dosage ; hypertension ; Hypertension - blood ; Hypertension - drug therapy ; Hypertension - physiopathology ; Japan ; losartan ; Losartan - administration &amp; dosage ; Male ; Medication Adherence ; Middle Aged ; Patient Satisfaction ; Sodium Chloride Symporter Inhibitors - administration &amp; dosage</subject><ispartof>Clinical and experimental hypertension (1993), 2011-08, Vol.33 (5), p.309-315</ispartof><rights>2011 Informa Healthcare USA, Inc. 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</citedby><cites>FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21649528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakima, Atsushi</creatorcontrib><creatorcontrib>Ohshiro, Katsuhiko</creatorcontrib><creatorcontrib>Nakada, Seigo</creatorcontrib><creatorcontrib>Yamazato, Masanobu</creatorcontrib><creatorcontrib>Kohagura, Kentaro</creatorcontrib><creatorcontrib>Nakamoto, Minori</creatorcontrib><creatorcontrib>Tana, Takeshi</creatorcontrib><creatorcontrib>Ohya, Yusuke</creatorcontrib><title>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</title><title>Clinical and experimental hypertension (1993)</title><addtitle>Clin Exp Hypertens</addtitle><description>The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.</description><subject>adherence</subject><subject>Aged</subject><subject>Angiotensin II Type 1 Receptor Blockers - administration &amp; dosage</subject><subject>Antihypertensive Agents - administration &amp; dosage</subject><subject>Blood Pressure - drug effects</subject><subject>combination therapy</subject><subject>Drug Combinations</subject><subject>Female</subject><subject>Humans</subject><subject>hydrochlorothiazide</subject><subject>Hydrochlorothiazide - administration &amp; dosage</subject><subject>hypertension</subject><subject>Hypertension - blood</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - physiopathology</subject><subject>Japan</subject><subject>losartan</subject><subject>Losartan - administration &amp; dosage</subject><subject>Male</subject><subject>Medication Adherence</subject><subject>Middle Aged</subject><subject>Patient Satisfaction</subject><subject>Sodium Chloride Symporter Inhibitors - administration &amp; dosage</subject><issn>1064-1963</issn><issn>1525-6006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAURSMEoqXwBwh5xyrFdmIn2YDagdKRikC0sLWc-Lnj4tjBdtROv4WPxdO0SGy6suV37r3Wu0XxmuDDiuDuHcG8Jh2vDinOT6zuKMdPin3CKCs5xvxpvmek3DF7xYsYrzAmNWft82KPEl53jLb7xZ_za5OGjXGX6GIDQU5bpIMf0U8ZjOwtlB99BPRltslMFtA3Yy1KHp2YG1DL7DxrM3c3WfmxN04m411EXqMjd2l8AheNQ-s1-g4DTMkHdGz98AtCRNKpnGvkrVEQkc6j0-0E4U7i3cvimZY2wqv786D4cfLpYnVann39vF4dnZVD3Vap5JLwSktSt03TdLWiWDOqKNVYDSBZxTuOOe81rWTf4rpRnAOHppKKMa6AVAfF28V3Cv73DDGJ0cQBrJUO_BxFm11b3BCcyXohh-BjDKDFFMwow1YQLHa1iIdaxK4WsdSSZW_uA-Z-BPVP9NBDBj4sgHF5CaO89sEqkeTW-qCDdIOJO_tHI97_57ABadNmkAHElZ-Dy_t7_I9_AeeXsVE</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Sakima, Atsushi</creator><creator>Ohshiro, Katsuhiko</creator><creator>Nakada, Seigo</creator><creator>Yamazato, Masanobu</creator><creator>Kohagura, Kentaro</creator><creator>Nakamoto, Minori</creator><creator>Tana, Takeshi</creator><creator>Ohya, Yusuke</creator><general>Informa Healthcare</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201108</creationdate><title>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</title><author>Sakima, Atsushi ; Ohshiro, Katsuhiko ; Nakada, Seigo ; Yamazato, Masanobu ; Kohagura, Kentaro ; Nakamoto, Minori ; Tana, Takeshi ; Ohya, Yusuke</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>adherence</topic><topic>Aged</topic><topic>Angiotensin II Type 1 Receptor Blockers - administration &amp; dosage</topic><topic>Antihypertensive Agents - administration &amp; dosage</topic><topic>Blood Pressure - drug effects</topic><topic>combination therapy</topic><topic>Drug Combinations</topic><topic>Female</topic><topic>Humans</topic><topic>hydrochlorothiazide</topic><topic>Hydrochlorothiazide - administration &amp; dosage</topic><topic>hypertension</topic><topic>Hypertension - blood</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - physiopathology</topic><topic>Japan</topic><topic>losartan</topic><topic>Losartan - administration &amp; dosage</topic><topic>Male</topic><topic>Medication Adherence</topic><topic>Middle Aged</topic><topic>Patient Satisfaction</topic><topic>Sodium Chloride Symporter Inhibitors - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakima, Atsushi</creatorcontrib><creatorcontrib>Ohshiro, Katsuhiko</creatorcontrib><creatorcontrib>Nakada, Seigo</creatorcontrib><creatorcontrib>Yamazato, Masanobu</creatorcontrib><creatorcontrib>Kohagura, Kentaro</creatorcontrib><creatorcontrib>Nakamoto, Minori</creatorcontrib><creatorcontrib>Tana, Takeshi</creatorcontrib><creatorcontrib>Ohya, Yusuke</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental hypertension (1993)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakima, Atsushi</au><au>Ohshiro, Katsuhiko</au><au>Nakada, Seigo</au><au>Yamazato, Masanobu</au><au>Kohagura, Kentaro</au><au>Nakamoto, Minori</au><au>Tana, Takeshi</au><au>Ohya, Yusuke</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension</atitle><jtitle>Clinical and experimental hypertension (1993)</jtitle><addtitle>Clin Exp Hypertens</addtitle><date>2011-08</date><risdate>2011</risdate><volume>33</volume><issue>5</issue><spage>309</spage><epage>315</epage><pages>309-315</pages><issn>1064-1963</issn><eissn>1525-6006</eissn><abstract>The efficacy and tolerability of switching therapy from free combinations of angiotensin II receptor blocker (ARB) and thiazide (A/T) to a fixed-dose of losartan and hydrochlorothiazide (L/H) has not been evaluated in Japan. We examined effects of switching therapy from variable-dose multiple-pill A/T to a fixed-dose L/H on blood pressure (BP) along with medication adherence and the degree of satisfaction in 91 hypertensive outpatients (mean age, 65.2 ± 9.6 years). After 6 months, a significant BP reduction (132 ± 9/76 ± 10 vs. 126 ± 12/72 ± 11 mm Hg), along with an improvement of attaining target BP (44.0 vs. 61.5%) and that of adherence, were observed. The magnitude of BP reduction in the participants increased their degree of satisfaction more significantly than in the participants who worsened their degree of satisfaction. The estimated glomerular filtration rate and the serum uric acid (UA) level decreased slightly but significantly. The hemoglobin A1c of participants with diabetes mellitus increased slightly but significantly. In conclusion, a switch in therapy from variable-dose, multiple-pill A/T combinations to a fixed-dose, single-pill L/H was effective in decreasing BP and serum UA in Japanese clinical practice. Metabolic side effects of L/H in patients with diabetes mellitus remain to be investigated.</abstract><cop>England</cop><pub>Informa Healthcare</pub><pmid>21649528</pmid><doi>10.3109/10641963.2010.549260</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1064-1963
ispartof Clinical and experimental hypertension (1993), 2011-08, Vol.33 (5), p.309-315
issn 1064-1963
1525-6006
language eng
recordid cdi_crossref_primary_10_3109_10641963_2010_549260
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects adherence
Aged
Angiotensin II Type 1 Receptor Blockers - administration & dosage
Antihypertensive Agents - administration & dosage
Blood Pressure - drug effects
combination therapy
Drug Combinations
Female
Humans
hydrochlorothiazide
Hydrochlorothiazide - administration & dosage
hypertension
Hypertension - blood
Hypertension - drug therapy
Hypertension - physiopathology
Japan
losartan
Losartan - administration & dosage
Male
Medication Adherence
Middle Aged
Patient Satisfaction
Sodium Chloride Symporter Inhibitors - administration & dosage
title Switching Therapy from Variable-Dose Multiple Pill to Fixed-Dose Single-Pill Combinations of Angiotensin II Receptor Blockers and Thiazides for Hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T11%3A57%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Switching%20Therapy%20from%20Variable-Dose%20Multiple%20Pill%20to%20Fixed-Dose%20Single-Pill%20Combinations%20of%20Angiotensin%20II%20Receptor%20Blockers%20and%20Thiazides%20for%20Hypertension&rft.jtitle=Clinical%20and%20experimental%20hypertension%20(1993)&rft.au=Sakima,%20Atsushi&rft.date=2011-08&rft.volume=33&rft.issue=5&rft.spage=309&rft.epage=315&rft.pages=309-315&rft.issn=1064-1963&rft.eissn=1525-6006&rft_id=info:doi/10.3109/10641963.2010.549260&rft_dat=%3Cproquest_cross%3E879480710%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-6a163fa14877794d20f52d22f0dcea53696066bf23ab8047d66e6e73ad556de13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=879480710&rft_id=info:pmid/21649528&rfr_iscdi=true